The rationale of this combination comes from the hypothesis that PARP inhibition in BRCA1/2 mutated cancer cells may elicit genomic instability, generating DNA fragments able to activate the intracellular stimulator of interferon genes pathway [40]. Here, BRCA1 is linked to cancer.